NCT07192926 2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
Clinical Trials
11 trialsNCT05348668 2026-01-07
Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer
Anhui Provincial Hospital
Phase 2 Completed
NCT07034118 2025-06-24
Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT05937438 2025-01-29
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT06693440 2024-11-18
The Immune Assessment of PD-1 Antibody Therapy in Tumor
Henan Cancer Hospital
Recruiting
NCT04891900 2024-07-08
TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital
Phase NA Active not recruiting
NCT06455072 2024-06-12
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
Fujian Cancer Hospital
Phase 2 Recruiting
NCT06321081 2024-03-20
ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
Beijing Hospital
Phase 2 Recruiting
NCT05007145 2021-12-21
REVO
Fujian Cancer Hospital
Phase 2 Unknown
NCT05001360 2021-10-27
Study of FMT Combined With Nivolumab in Gastric Cancer
Fujian Cancer Hospital
Phase NA Withdrawn
NCT04613804 2020-11-03
Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy
Fujian Cancer Hospital
Phase 2 Unknown